Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic optio...
Gespeichert in:
| Veröffentlicht in: | Journal of heterocyclic chemistry 2023-02, Vol.60 (2), p.165-182 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 182 |
|---|---|
| container_issue | 2 |
| container_start_page | 165 |
| container_title | Journal of heterocyclic chemistry |
| container_volume | 60 |
| creator | Kabi, Arup K. Pal, Maynak Gujjarappa, Raghuram Malakar, Chandi C. Roy, Mithun |
| description | The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic options to design an adequate treatment for infected patients immediately. In this strategy, Remdesivir (Veklury), Hydroxychloroquine appears to be the drug of choice and garnered unprecedented attention as potential therapeutic agents against the pandemic realized worldwide due to SARS‐CoV‐2 infection. These are the breathtaking instances of possible repositioning of drugs, whose pharmacokinetics and optimal dosage are familiar. In this review, we provide an overview of these medications, their synthesis, and the possible mechanism of action against SARS‐CoV‐2.
Comprehensive overview on synthesis and mode of actions of antimalarial and antiviral drugs (Remdesivir, Chloroquine, and Hydroxychloroquine) have been furnished to contribute toward the drug repositioning for treatment of severe acute respiratory syndrome coronavirus 2 infection. |
| doi_str_mv | 10.1002/jhet.4541 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9349740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2700313376</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3731-f5b95b8a734caf9af9c285a409d119c7a887ea5907d7a312c9a5009b3587d6843</originalsourceid><addsrcrecordid>eNp1kd9qFDEUxoModq1e-AIS8Ka9mDZ_JpvJjVCW6iqFQlvFu5DNnHGzzCTbZGbr3PkIPqNPYsatRQUhJBy-3_k4Jx9CLyk5oYSw080a-pNSlPQRmlFV8kJQxR-jWdZYQQX7fICepbTJJeVSPkUHXKiSMSJm6PZyB3Hn4A6HBi_HOoavo123IYbbwXnAxtf4Croaktu5iIPHCXJHFuzQA46Qti6aPsQRp9Hn9g6wzd3eZHxImOGj67Or6x_fvi_Cp3yz4-foSWPaBC_u30P08e35zWJZXFy-e784uygsl5wWjVgpsaqM5KU1jcrHskqYkqiaUmWlqSoJRigia2k4ZVYZQYhacVHJel6V_BC92ftuh1UHtQXfR9PqbXSdiaMOxum_Fe_W-kvYacVLJUuSDY7uDabPgNTrziULbWs8hCFpJgnhlHM5z-jrf9BNGKLP62Uqb1CJaj4ZHu8pG0NKEZqHYSjRU5B6ClJPQWb21Z_TP5C_k8vA6R64cy2M_3fSH5bnN78sfwLumatn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2773485860</pqid></control><display><type>article</type><title>Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kabi, Arup K. ; Pal, Maynak ; Gujjarappa, Raghuram ; Malakar, Chandi C. ; Roy, Mithun</creator><creatorcontrib>Kabi, Arup K. ; Pal, Maynak ; Gujjarappa, Raghuram ; Malakar, Chandi C. ; Roy, Mithun</creatorcontrib><description>The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic options to design an adequate treatment for infected patients immediately. In this strategy, Remdesivir (Veklury), Hydroxychloroquine appears to be the drug of choice and garnered unprecedented attention as potential therapeutic agents against the pandemic realized worldwide due to SARS‐CoV‐2 infection. These are the breathtaking instances of possible repositioning of drugs, whose pharmacokinetics and optimal dosage are familiar. In this review, we provide an overview of these medications, their synthesis, and the possible mechanism of action against SARS‐CoV‐2.
Comprehensive overview on synthesis and mode of actions of antimalarial and antiviral drugs (Remdesivir, Chloroquine, and Hydroxychloroquine) have been furnished to contribute toward the drug repositioning for treatment of severe acute respiratory syndrome coronavirus 2 infection.</description><identifier>ISSN: 0022-152X</identifier><identifier>EISSN: 1943-5193</identifier><identifier>DOI: 10.1002/jhet.4541</identifier><identifier>PMID: 35942205</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Inc</publisher><subject>Chemical compounds ; Drugs ; Emergency medical services ; Health hazards ; Pharmacology ; Public health ; Respiratory diseases ; Review ; Reviews ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Viral diseases</subject><ispartof>Journal of heterocyclic chemistry, 2023-02, Vol.60 (2), p.165-182</ispartof><rights>2022 Wiley Periodicals LLC.</rights><rights>2023 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3731-f5b95b8a734caf9af9c285a409d119c7a887ea5907d7a312c9a5009b3587d6843</citedby><cites>FETCH-LOGICAL-c3731-f5b95b8a734caf9af9c285a409d119c7a887ea5907d7a312c9a5009b3587d6843</cites><orcidid>0000-0002-9478-017X ; 0000-0002-2586-3190</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjhet.4541$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjhet.4541$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35942205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kabi, Arup K.</creatorcontrib><creatorcontrib>Pal, Maynak</creatorcontrib><creatorcontrib>Gujjarappa, Raghuram</creatorcontrib><creatorcontrib>Malakar, Chandi C.</creatorcontrib><creatorcontrib>Roy, Mithun</creatorcontrib><title>Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</title><title>Journal of heterocyclic chemistry</title><addtitle>J Heterocycl Chem</addtitle><description>The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic options to design an adequate treatment for infected patients immediately. In this strategy, Remdesivir (Veklury), Hydroxychloroquine appears to be the drug of choice and garnered unprecedented attention as potential therapeutic agents against the pandemic realized worldwide due to SARS‐CoV‐2 infection. These are the breathtaking instances of possible repositioning of drugs, whose pharmacokinetics and optimal dosage are familiar. In this review, we provide an overview of these medications, their synthesis, and the possible mechanism of action against SARS‐CoV‐2.
Comprehensive overview on synthesis and mode of actions of antimalarial and antiviral drugs (Remdesivir, Chloroquine, and Hydroxychloroquine) have been furnished to contribute toward the drug repositioning for treatment of severe acute respiratory syndrome coronavirus 2 infection.</description><subject>Chemical compounds</subject><subject>Drugs</subject><subject>Emergency medical services</subject><subject>Health hazards</subject><subject>Pharmacology</subject><subject>Public health</subject><subject>Respiratory diseases</subject><subject>Review</subject><subject>Reviews</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Viral diseases</subject><issn>0022-152X</issn><issn>1943-5193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kd9qFDEUxoModq1e-AIS8Ka9mDZ_JpvJjVCW6iqFQlvFu5DNnHGzzCTbZGbr3PkIPqNPYsatRQUhJBy-3_k4Jx9CLyk5oYSw080a-pNSlPQRmlFV8kJQxR-jWdZYQQX7fICepbTJJeVSPkUHXKiSMSJm6PZyB3Hn4A6HBi_HOoavo123IYbbwXnAxtf4Croaktu5iIPHCXJHFuzQA46Qti6aPsQRp9Hn9g6wzd3eZHxImOGj67Or6x_fvi_Cp3yz4-foSWPaBC_u30P08e35zWJZXFy-e784uygsl5wWjVgpsaqM5KU1jcrHskqYkqiaUmWlqSoJRigia2k4ZVYZQYhacVHJel6V_BC92ftuh1UHtQXfR9PqbXSdiaMOxum_Fe_W-kvYacVLJUuSDY7uDabPgNTrziULbWs8hCFpJgnhlHM5z-jrf9BNGKLP62Uqb1CJaj4ZHu8pG0NKEZqHYSjRU5B6ClJPQWb21Z_TP5C_k8vA6R64cy2M_3fSH5bnN78sfwLumatn</recordid><startdate>202302</startdate><enddate>202302</enddate><creator>Kabi, Arup K.</creator><creator>Pal, Maynak</creator><creator>Gujjarappa, Raghuram</creator><creator>Malakar, Chandi C.</creator><creator>Roy, Mithun</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9478-017X</orcidid><orcidid>https://orcid.org/0000-0002-2586-3190</orcidid></search><sort><creationdate>202302</creationdate><title>Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</title><author>Kabi, Arup K. ; Pal, Maynak ; Gujjarappa, Raghuram ; Malakar, Chandi C. ; Roy, Mithun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3731-f5b95b8a734caf9af9c285a409d119c7a887ea5907d7a312c9a5009b3587d6843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chemical compounds</topic><topic>Drugs</topic><topic>Emergency medical services</topic><topic>Health hazards</topic><topic>Pharmacology</topic><topic>Public health</topic><topic>Respiratory diseases</topic><topic>Review</topic><topic>Reviews</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kabi, Arup K.</creatorcontrib><creatorcontrib>Pal, Maynak</creatorcontrib><creatorcontrib>Gujjarappa, Raghuram</creatorcontrib><creatorcontrib>Malakar, Chandi C.</creatorcontrib><creatorcontrib>Roy, Mithun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of heterocyclic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kabi, Arup K.</au><au>Pal, Maynak</au><au>Gujjarappa, Raghuram</au><au>Malakar, Chandi C.</au><au>Roy, Mithun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</atitle><jtitle>Journal of heterocyclic chemistry</jtitle><addtitle>J Heterocycl Chem</addtitle><date>2023-02</date><risdate>2023</risdate><volume>60</volume><issue>2</issue><spage>165</spage><epage>182</epage><pages>165-182</pages><issn>0022-152X</issn><eissn>1943-5193</eissn><abstract>The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic options to design an adequate treatment for infected patients immediately. In this strategy, Remdesivir (Veklury), Hydroxychloroquine appears to be the drug of choice and garnered unprecedented attention as potential therapeutic agents against the pandemic realized worldwide due to SARS‐CoV‐2 infection. These are the breathtaking instances of possible repositioning of drugs, whose pharmacokinetics and optimal dosage are familiar. In this review, we provide an overview of these medications, their synthesis, and the possible mechanism of action against SARS‐CoV‐2.
Comprehensive overview on synthesis and mode of actions of antimalarial and antiviral drugs (Remdesivir, Chloroquine, and Hydroxychloroquine) have been furnished to contribute toward the drug repositioning for treatment of severe acute respiratory syndrome coronavirus 2 infection.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Inc</pub><pmid>35942205</pmid><doi>10.1002/jhet.4541</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-9478-017X</orcidid><orcidid>https://orcid.org/0000-0002-2586-3190</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-152X |
| ispartof | Journal of heterocyclic chemistry, 2023-02, Vol.60 (2), p.165-182 |
| issn | 0022-152X 1943-5193 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9349740 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Chemical compounds Drugs Emergency medical services Health hazards Pharmacology Public health Respiratory diseases Review Reviews Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Viral diseases |
| title | Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overview%20of%20Hydroxychloroquine%20and%20Remdesivir%20on%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS%E2%80%90CoV%E2%80%902)&rft.jtitle=Journal%20of%20heterocyclic%20chemistry&rft.au=Kabi,%20Arup%20K.&rft.date=2023-02&rft.volume=60&rft.issue=2&rft.spage=165&rft.epage=182&rft.pages=165-182&rft.issn=0022-152X&rft.eissn=1943-5193&rft_id=info:doi/10.1002/jhet.4541&rft_dat=%3Cproquest_pubme%3E2700313376%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2773485860&rft_id=info:pmid/35942205&rfr_iscdi=true |